发明名称 AMINOBENZOPHENONES AS INHIBITORS OF IL-1.BETA. AND TNF-.ALPHA.
摘要 The present invention relates to compounds of formula (I) wherein R1 and R2 independently represent one or more, same or different substituents selected from the group consisting of halogen, hydroxy, mercapto, trifluoromethyl, amino (C1-C3)alkyl, (C2-C3)olefinic group, (C1-C3)alkoxy, (C1-C3)alkylthio, (C1-C6)alkylamino, (C1-C3)alkoxycarbonyl, cyano, carbamoyl, phenyl, or nitro ; R2 further being represented by hydrogen; R3 represents hydrogen, halogen, hydroxy, mercapto, trifluoromethyl, amino, (C1-C3)alkyl, (C2-C3)olefinic group, (C1-C3)alkoxy, (C1-C3)alkylthio, (C1-C6)alkylamino, (C1- C3)alkoxycarbonyl, phenyl, cyano, carboxy or carbamoyl; R4 represents hydrogen, (C1-C3)alkyl, or allyl; X represents oxygen or sulphur; with the proviso that formula (I) does not comprise the compound 2,2,2-trifluoro- N-[2-[3-chloro-4-(2-methylbenzoyl)-phenylamino]-phenyl]acetamide wherein R1 is a 2-methyl, R2 is 2-chloro, R3 and R4 is hydrogen, and X is oxygen; and a salt thereof with a pharmaceutically acceptable acid, a hydrat e or a solvate thereof. The compounds are valuable in the human and veterinary therapy.
申请公布号 CA2379319(A1) 申请公布日期 2001.01.25
申请号 CA20002379319 申请日期 2000.07.11
申请人 LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSA KTI 发明人 OTTOSEN, ERIK RYTTER
分类号 A61P1/00;A61K31/165;A61K31/167;A61K45/06;A61P9/10;A61P11/06;A61P17/00;A61P17/06;A61P19/02;A61P19/06;A61P19/10;A61P29/00;A61P31/04;A61P31/18;A61P37/08;C07C225/22;C07C233/43;(IPC1-7):C07C233/43 主分类号 A61P1/00
代理机构 代理人
主权项
地址